NumFin

Myriad Genetics, Inc.

Sümbol: MYGN

NASDAQ

21.6

USD

Turuhind täna

  • -7.5210

    P/E suhe

  • -0.4011

    PEG suhe

  • 1.94B

    MRK Cap

  • 0.00%

    DIV tootlus

Myriad Genetics, Inc. (MYGN) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Myriad Genetics, Inc. (MYGN) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Myriad Genetics, Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM202220212019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

balance-sheet.row.cash-and-short-term-investments

0114.9339.8136.9
136.9
180.6
150.7
159
144.8
270.6
531.1
454.2
346.5
403.2
316.9
328.7
308.3
227.7
113.8
115.4
72.8
73.1
127.2
80.5
9.9
14.6
15.7
13.2

balance-sheet.row.short-term-investments

05881.443.7
43.7
69.7
48.3
90.5
80.7
121.6
268.2
254.2
293.8
310.4
253.3
91
164.9
129.2
64.3
31.4
11.2
12
91.3
24.3
4.5
0
0
0

balance-sheet.row.net-receivables

0101.691.3138.6
138.6
102.1
111.3
95
87.7
98.7
97.7
63.1
50.3
48.1
45.3
45.4
32.5
22.2
18.4
14.5
22.3
7.5
5.8
2.8
3.2
0.6
0.5
0

balance-sheet.row.inventory

020.115.331.4
31.4
34.3
42.2
38.3
25.1
23.9
5
11.6
5.7
-399.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

020.438.441.7
46.4
9.4
12.9
22.2
26
27
9
7.3
417.9
488.4
4
3.1
2.5
2.3
3.3
7.3
7.7
4.8
4.2
2.7
0.6
16.5
32.4
37.4

balance-sheet.row.total-current-assets

0274.6484.8348.6
348.6
326.4
317.1
314.5
283.6
400.1
634.7
530.6
479.3
540.6
366.2
377.3
343.3
252.3
135.6
137.2
102.8
85.4
137.2
85.9
13.7
31.7
48.6
50.6

balance-sheet.row.property-plant-equipment-net

0187.3125.357.3
57.3
43.2
51.1
58.3
67.2
34.6
27.6
24.2
23.1
23.3
22.6
30
24.9
19.8
18.5
17.3
18.7
15.4
12.7
11.3
10
12.4
12
9.4

balance-sheet.row.goodwill

0286.8239.2417.2
417.2
318.6
316.1
195.3
177.2
169.2
56.9
56.9
56.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0379.7404.1684.7
684.7
455.2
491.6
227.5
192.6
205.3
13.3
15.7
16.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0666.5643.31101.9
1101.9
773.8
807.7
422.8
369.8
374.5
70.2
72.6
72.8
-85.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

054.85954.9
54.9
30.7
48.5
79.9
40.6
84.1
158.7
113.7
70.9
85.2
75.4
91.3
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
9.6
36.6
36.2
35.7
28
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

015.58.30
-1214.1
0
0
5
5
-79.1
-124.1
-86.7
-70.9
2.1
2.3
0.7
3.9
4.5
4.9
33.8
61.3
56.6
22.2
9.2
29.9
23.3
15.5
19.6

balance-sheet.row.total-non-current-assets

0924.1835.91214.1
1214.1
847.7
907.3
566
482.6
423.7
169.1
160
131.5
53.3
100.3
122
28.8
24.3
23.4
51.2
80
72
34.9
20.4
39.9
35.7
27.5
29

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

01198.71320.71562.7
1562.7
1174.1
1224.4
880.5
766.2
823.8
803.8
690.6
610.8
593.8
466.4
499.3
372.1
276.6
159
188.4
182.8
157.4
172.1
106.4
53.6
67.4
76.1
79.6

balance-sheet.row.account-payables

028.829.633.3
33.3
26
22
21.1
21.1
23.1
18.1
10.1
11.4
8.9
14.2
24.9
15.8
11.8
11.9
7.9
11.5
9.5
9.7
4.3
2.9
5.1
2.6
2.2

balance-sheet.row.short-term-debt

014.11378.9
78.9
68.3
65.6
0
0
0
0
0
9.6
0
0
0
0
0
0
0
0
3.6
0
0
0
0.1
0.3
0.3

balance-sheet.row.tax-payables

04.843
3
4.3
7.1
2.8
3.8
277.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0130.979.3233.5
233.5
9.3
99.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.5

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

093.7156.53.4
82.3
5.3
127.3
49.5
46.1
56.4
44.3
32.8
21.6
27.4
18
46.8
15.6
14.9
10.1
5.9
4.9
1
3.1
24.4
2.4
4.7
6.9
6.5

balance-sheet.row.total-non-current-liabilities

0175.7148.6356
356
107
229.1
60.1
35.4
24.2
10.7
10
9.6
8.8
14.2
26.9
16.1
11.9
13.1
9.1
14.4
23.9
29.5
4.3
0.1
5.2
0.1
0.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
-9.6
-8.8
-14.2
-26.9
-16.1
-11.9
-13.1
-9.1
-14.4
-23.9
-29.5
-4.3
0
-5.2
0
0

balance-sheet.row.capital-lease-obligations

014592.370.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0312.9352.9473.8
473.8
209.2
446.6
132.4
104.1
104.8
75.2
55
44
36.3
32.2
73.7
31.7
26.8
23.3
15.1
19.3
28.5
32.6
28.7
5.4
9.9
9.9
9.4

balance-sheet.row.preferred-stock

0000
5.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

00.80.80.7
0.7
0.7
0.7
0.7
0.7
0.7
0.8
0.8
0.9
0.9
1
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0
0
0

balance-sheet.row.retained-earnings

0-366.2-254.225.6
25.6
52.8
-68.4
-73.2
-77
2
30.9
-12.7
-38.6
-10.5
-119.9
-204.6
-252.4
-217.4
-179.2
-139.3
-98.7
-73.8
-59.8
-52.7
-43.9
-33.9
-24.1
-14.9

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-8.9-5.1-5.4
-5.4
-4
-5.5
-9.5
-7
-1.5
-0.4
-0.2
0.2
0.1
2.8
-0.2
-0.4
-0.7
-0.5
-0.2
0.7
0.3
0.4
-0.1
-0.3
0
0
0

balance-sheet.row.other-total-stockholders-equity

01260.11226.31068
1068
915.4
851.4
830.1
745.4
717.8
697.3
647.7
604.4
567
550.4
630
592.7
467.6
315.1
312.5
261.2
202.1
198.8
130.2
92.3
91.4
90.3
85.1

balance-sheet.row.total-stockholders-equity

0885.8967.81088.9
1088.9
964.9
778.2
748.1
662.1
719
728.6
635.7
566.8
557.6
434.2
425.7
340.4
249.8
135.7
173.3
163.5
128.9
139.6
77.7
48.2
57.5
66.2
70.2

balance-sheet.row.total-liabilities-and-stockholders-equity

01198.71320.71562.7
1562.7
1174.1
1224.4
880.5
766.2
823.8
803.8
690.6
610.8
593.8
466.4
499.3
372.1
276.6
159
188.4
182.8
157.4
172.1
106.4
53.6
67.4
76.1
79.6

balance-sheet.row.minority-interest

0000
0
0
-0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0---
1088.9
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0112.8140.498.6
98.6
100.4
96.8
170.4
121.3
205.8
427
367.9
364.6
395.5
328.7
182.3
164.9
129.2
64.3
31.4
11.2
12
91.3
24.3
4.5
0
0
0

balance-sheet.row.total-debt

014592.3233.5
233.5
9.3
99.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.4
0.8

balance-sheet.row.net-debt

088.1-166.1140.3
140.3
-101.6
-3.3
-68.5
-64.1
-64.8
-104.1
-86.4
-52.7
-92.8
-63.5
-237.7
-143.4
-98.6
-49.5
-84
-61.6
-61.1
-35.9
-56.2
-5.4
-14.5
-15.3
-12.4

Rahavoogude aruanne

Myriad Genetics, Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM202220212019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

cash-flows.row.net-income

0-112-27.24.6
4.6
131
21.8
125.3
80.2
176.2
147.1
112.2
100.7
152.3
84.6
47.8
-35
-38.2
-40
-40.6
-24.8
-14
-7.2
-8.7
-10
-9.8
-9.2
-5.9

cash-flows.row.depreciation-and-amortization

052.762.873
73
54.4
48.3
26.7
25
13.8
8.9
9.1
7.2
7.1
9.4
8.8
7.5
6.9
6.1
5.8
5.3
4.5
3.7
3.3
3.2
3.3
2.5
1.6

cash-flows.row.deferred-income-tax

0-31.9-34.713.1
13.1
-23.7
2.5
15.7
1.7
7.5
8.2
34.2
40.4
-28.1
0.5
0
0
0.2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

038.136.333.5
33.5
27.1
29.9
31.6
45.7
27.1
26.6
26.3
25.1
22.8
25.7
0
0
-0.2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-101.5120.4-37.1
-37.1
-21.6
-36.6
-65.4
-40.7
-60
-41
-28.8
38.5
-27.4
-54.1
16.9
-11.2
-1.4
6.1
1.9
-27.3
-7.3
-0.7
22.1
-7.5
-0.6
-0.1
5.6

cash-flows.row.account-receivables

0-10.3-8.8-18.2
-18.2
-39.2
-41.4
-39.2
-34.4
-24.4
-67.2
-34.9
-15
-21.7
-19.9
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-2.91.68
8
7.9
-1.2
-14.6
-0.8
-15.8
6.6
-3.4
0.2
-0.5
-21.5
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

0-3.59.21.1
1.1
4
-3
-11.4
-3.1
-1.5
8
-1.2
0.3
-5.3
-10.7
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-84.8118.4-28
-28
5.7
9
-0.2
-2.4
-18.3
11.6
10.9
53
0
-2
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

048.3-139.4-3.4
-3.4
-51.3
40.3
32.4
28.6
25.6
24.1
-11.1
-81.2
28.4
17.9
30.3
12.7
4.7
4.5
2
0.4
0.5
0.4
0.5
0.2
0.1
0.2
0.1

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-45.3-18-8.6
-8.6
-8.4
-6.1
-5
-23.9
-14.3
-11.4
-10.2
-5.8
0
-7.5
-13.7
-11.4
-7.7
-6.7
-3.9
-8
-6.9
-5.3
-4.6
-4
-3.2
-4.7
-6.4

cash-flows.row.acquisitions-net

0-57.2379.1-278.5
-278.5
8.4
-216.1
-37
-20.1
-223.5
-5
-0.8
-79.4
0
7.5
0
0
0
0
0
0
0
0
0
0
0
0.1
0

cash-flows.row.purchases-of-investments

0-103.2-147.8-78.5
-78.5
-80.9
-87.5
-164.5
-80.7
-161.8
-443.8
-396.1
-425.2
-477.6
-308.6
-191.7
-197.8
-165.5
-44.6
-52.7
-51.8
-89.8
-249.3
-24
-291.7
-840.6
-582.8
-622.2

cash-flows.row.sales-maturities-of-investments

0128.261.179.2
79.2
77.7
163.4
115.1
165.6
381.9
384.6
385.2
456.1
52.2
111.8
174.4
162.5
100.5
71
58.6
50.7
137.2
172.2
25
300.2
841.1
592.2
569.6

cash-flows.row.other-investing-activites

0000
0
-8.4
0
0
0
0
0
-17.1
-0.1
348.7
-9.6
-0.3
0
-0.1
-0.1
-0.1
-2.9
-2.5
-2.7
-0.8
0
0
-0.1
0

cash-flows.row.net-cash-used-for-investing-activites

0-77.5274.4-286.4
-286.4
-11.6
-146.3
-91.4
40.9
-17.7
-75.6
-38.9
-54.4
-76.7
-206.3
-31.3
-46.7
-72.8
19.5
1.9
-12
38.1
-85.1
-4.3
4.5
-2.7
4.7
-59

cash-flows.row.debt-repayment

00-226.4-115
-115
-143
-305
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

06.391.88.7
8.7
36.9
6
0
30
0
0
0
25.1
22.3
84.2
21.9
117.5
149.9
2.5
51.3
59
3.4
68.6
38
0.6
0.6
4.6
59.2

cash-flows.row.common-stock-repurchased

000-50
-50
0
-31.6
-162.6
-210.7
-287.7
-146.3
-128.5
-200.5
-71.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

000-340
-340
0
-403
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0-14.3-16678.6
338.6
11.1
805.4
94.3
3.4
75.9
65.7
59.2
58.8
0
-136.1
0
0
0
0
0
0
0
0
0
-0.2
-0.4
-0.3
-0.3

cash-flows.row.net-cash-used-provided-by-financing-activities

0-8-150.6182.3
182.3
-95
71.8
-68.3
-177.3
-211.8
-80.6
-69.2
-116.6
-49.1
-51.9
21.9
117.5
149.9
2.5
51.3
59
3.4
68.6
38
0.4
0.2
4.3
58.9

cash-flows.row.effect-of-forex-changes-on-cash

0-0.6-0.62.7
2.7
-0.8
2.2
-2.2
-4.8
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0
0
0
-14.6
-15.6
-13.2

cash-flows.row.net-change-in-cash

0-192.4141.4-17.7
-17.7
8.5
33.9
4.4
-0.7
-39.3
17.7
33.7
-40.2
29.3
-174.2
94.3
44.9
49.1
-1.3
22.4
0.5
25.1
-20.3
50.8
-9.2
-24.1
-13.2
-11.9

cash-flows.row.cash-at-end-of-period

066.4258.493.2
93.2
110.9
102.4
68.5
64.1
64.8
104.1
86.4
52.7
92.8
63.5
237.7
143.4
98.6
49.5
84
61.6
61.1
35.9
56.2
5.4
0
0
0

cash-flows.row.cash-at-beginning-of-period

0258.8117110.9
110.9
102.4
68.5
64.1
64.8
104.1
86.4
52.7
92.8
63.5
237.7
143.4
98.6
49.5
50.8
61.6
61.1
35.9
56.2
5.4
14.6
24.1
13.2
11.9

cash-flows.row.operating-cash-flow

0-106.318.283.7
83.7
115.9
106.2
166.3
140.5
190.2
173.9
141.8
130.8
155.1
84
103.7
-25.9
-28
-23.3
-30.9
-46.5
-16.3
-3.8
17.2
-14.1
-7
-6.6
1.4

cash-flows.row.capital-expenditure

0-45.3-18-8.6
-8.6
-8.4
-6.1
-5
-23.9
-14.3
-11.4
-10.2
-5.8
0
-7.5
-13.7
-11.4
-7.7
-6.7
-3.9
-8
-6.9
-5.3
-4.6
-4
-3.2
-4.7
-6.4

cash-flows.row.free-cash-flow

0-151.60.275.1
75.1
107.5
100.1
161.3
116.6
175.9
162.5
131.7
125
155.1
76.5
90.1
-37.3
-35.7
-30
-34.8
-54.6
-23.2
-9
12.5
-18.1
-10.2
-11.3
-5

Kasumiaruande rida

Myriad Genetics, Inc. tulud muutusid võrreldes eelmise perioodiga NaN%. MYGN brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM202220212019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

income-statement-row.row.total-revenue

0678.4690.6851.1
851.1
772.6
771.4
753.8
723.1
778.2
613.2
496
402.1
362.6
326.5
333.6
157.1
114.3
82.4
56.6
64.3
53.8
45.2
34
25.3
23.2
15.2
6.6

income-statement-row.row.cost-of-revenue

0202197.6201
201
177.2
171.2
157.3
147.4
109.2
79.6
64.7
46.7
44.3
43.3
32.3
30.8
27.6
20.3
13.8
12.6
10.7
7.4
0.7
-0.1
-1.9
-2.2
-1.6

income-statement-row.row.gross-profit

0476.4493650.1
650.1
595.4
600.2
596.5
575.7
669
533.5
431.3
355.4
318.4
283.3
301.3
126.3
86.6
62.1
42.9
51.8
43.1
37.8
33.3
25.4
25.1
17.4
8.2

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00.6139.31.2
1.2
-0.4
-2.5
1.2
0.3
-2
-0.2
-0.4
0
0
0
0
0
0
0
0
0
0
0
3.3
3.2
3.3
2.5
1.6

income-statement-row.row.operating-expenses

0600.1681.7641.4
641.4
537.9
550.8
429.7
441.5
394.6
305.5
251
197.6
183.3
156.8
263.2
174
132.2
102.8
85.5
79.1
61.8
50.9
44.9
37.8
38.1
29.9
17.1

income-statement-row.row.cost-and-expenses

0802.1879.3842.4
842.4
715.1
722
587
588.9
503.8
385.2
315.7
244.3
227.6
200.1
295.5
204.9
159.9
123.2
99.3
91.7
72.5
58.3
45.6
37.7
36.2
27.7
15.5

income-statement-row.row.interest-income

02.60.73.2
3.2
1.8
1.2
0.9
0.4
5.4
5.5
4.6
2.2
5.7
12.5
13.7
12.1
7.4
2.8
0
2.9
5.4
0
0
0
0
0
0

income-statement-row.row.interest-expense

03.26.612
12
3.2
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-16.9-8.40.1
0.1
60.8
-1.7
1.2
0.3
-2
-0.2
-0.4
-0.4
0.1
-2.5
-3.3
0.7
0
-2
0
0
-0.2
-0.3
-0.4
12.4
3.2
3.3
3.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00.6139.31.2
1.2
-0.4
-2.5
1.2
0.3
-2
-0.2
-0.4
0
0
0
0
0
0
0
0
0
0
0
3.3
3.2
3.3
2.5
1.6

income-statement-row.row.total-operating-expenses

0-16.9-8.40.1
0.1
60.8
-1.7
1.2
0.3
-2
-0.2
-0.4
-0.4
0.1
-2.5
-3.3
0.7
0
-2
0
0
-0.2
-0.3
-0.4
12.4
3.2
3.3
3.1

income-statement-row.row.interest-expense

03.26.612
12
3.2
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

055.962.873
73
54.4
48.3
26.7
25
13.8
8.9
9.1
7.2
7.1
9.4
8.8
7.5
6.9
6.1
5.8
5.3
4.5
3.7
3.3
3.2
3.3
2.5
1.6

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-123.7-48.77.6
7.6
118.7
49.4
166.8
134.2
274.4
228
180.3
157.8
135.1
126.5
38.1
-47.7
-45.6
-40.7
-42.6
-27.3
-18.7
-13.1
-11.5
-12.4
-13
-12.5
-8.9

income-statement-row.row.income-before-tax

0-140.6-57.10.2
7.7
116.9
42.9
168.9
134.9
277.9
233.3
184.5
159.7
140.8
136.4
48.5
-35
-38.2
-40
-40.6
-24.4
-13.5
-6.6
-8.7
-10
-9.8
-9.2
-5.9

income-statement-row.row.income-tax-expense

0-28.6-29.9-4.4
-4.4
-13.9
21.3
43.6
54.7
101.6
86.1
72.4
58.9
-11.5
0.2
0.6
35
-7.4
-0.8
-2
0.4
0.5
0.6
8.7
10
9.8
9.2
5.9

income-statement-row.row.net-income

0-112-27.24.6
4.6
131
21.8
125.3
80.2
176.2
147.1
112.2
100.7
152.3
84.6
47.8
-35
-38.2
-40
-40.6
-24.8
-14
-7.2
-8.7
-10
-9.8
-9.2
-5.9
Sarnased aktsiad
Sind võib huvitada ka:
THYROCARE.BO
Thyrocare Technologies Limited.
605.85 INR
BSE
HTGM
HTG Molecular Diagnostics, Inc..
0.48 USD
NASDAQ
CO
Global Cord Blood Corporation.
2.9876 USD
NYSE
ANPCF
ANGLE plc.
0.16678 USD
PNK
DIUXF
Diaceutics PLC.
1.3672 USD
PNK
CNTG
Centogene N.V..
0.71 USD
NASDAQ
DMTK
DermTech, Inc..
0.6906 USD
NASDAQ
HTGMQ
HTG Molecular Diagnostics, Inc..
0.0015 USD
PNK
SQIDF
SQI Diagnostics Inc..
0.0149 USD
PNK

Korduma kippuv küsimus

Mis on Myriad Genetics, Inc. (MYGN) koguvara?

Myriad Genetics, Inc. (MYGN) koguvara on 1198700000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.689.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -1.692.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -0.374.

Mis on ettevõtte kogutulu?

Kogutulu on -0.370.

Mis on Myriad Genetics, Inc. (MYGN) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -112000000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 145000000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 600100000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.